Inventor · disambiguated record
Antonio Mete
Also filed as: METE ANTONIO
16 granted patents·14 pending applications·22 citations·filing 1990–2023
87Inventor score
Files withASTRAZENECA AB9ACESION PHARMA APS5FORD RHONAN5JAGUAHR THERAPEUTICS PTE LTD2BULL RICHARD JAMES1
Top patents by PatentIndex Score
30 records- 0172US6743939B2Phenylheteroalkylamine derivativesASTRAZENECA AB·Filed 2001·Granted Jun 1, 2004·11 cites·29 claims
- 0268US8193239B2Substituted 1-cyanoethylheterocyclylcarboxamide compoundsFORD RHONAN·Filed 2010·Granted Jun 5, 2012·3 cites·9 claims
- 0364US12030856B2Potassium channel inhibitorsACESION PHARMA APS·Filed 2023·Granted Jul 9, 2024·0 cites·14 claims
- 0464US11945811B2Potassium channel inhibitorsACESION PHARMA APS·Filed 2023·Granted Apr 2, 2024·0 cites·20 claims
- 0563US6887871B2Use of phenylheteroakylamine derivativesASTRAZENECA AB·Filed 2001·Granted May 3, 2005·2 cites·6 claims
- 0662US8329729B2Quinuclidine derivatives as muscarinic M3 receptor antagonistsBULL RICHARD JAMES·Filed 2008·Granted Dec 11, 2012·1 cites·7 claims
- 0761US6900243B2Phenylheteroalkylamine derivativesASTRAZENECA AB·Filed 2001·Granted May 31, 2005·1 cites·16 claims
- 0860US2010144759A1Novel n-(fluoro-pyrazinyl)-phenylsulfonamides as modulators of chemokine receptor ccr4ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0952US2008293742A1Novel N-(Fluoro-Pyrazinyl)-Phenylsulfonamides as Modulators of Chemokine Receptor Ccr4CHESHIRE DAVID·Filed 2006·Application pending·0 cites
- 1048US8207193B2Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonistsFORD RHONAN·Filed 2007·Granted Jun 26, 2012·0 cites·15 claims
- 1148US5225423AButenone compounds, their preparation and their use as pesticidesSHELL RES LTD·Filed 1990·Granted Jul 6, 1993·4 cites·13 claims
- 1245US12221439B2Tetrahydropyridopyrimidine derivatives as AhR modulatorsJAGUAHR THERAPEUTICS PTE LTD·Filed 2019·Granted Feb 11, 2025·0 cites·20 claims
- 1345US2009233965A1Alkyl Esters Of Cyclic Amino Alcohols With Muscarinic M3 Receptor Antagonist Activity, Useful For Treating E.G. Chronic Bronchial Obstruction, Asthma And Overactive BladderASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1445US2006128723A1Sulptionamide compounds that modulate chemokine receptor activity (CCR4)METE ANTONIO·Filed 2004·Application pending·0 cites
- 1544US7329686B2Substituted thiophene compoundsASTRAZENECA AB·Filed 2003·Granted Feb 12, 2008·0 cites·7 claims
- 1643US11098018B2Potassium channel inhibitorsACESION PHARMA APS·Filed 2018·Granted Aug 24, 2021·0 cites·31 claims
- 1743US2013005695A1Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonistsASTRAZENECA AB·Filed 2012·Application pending·0 cites
- 1842US11168074B2Potassium channel inhibitorsACESION PHARMA APS·Filed 2018·Granted Nov 9, 2021·0 cites·32 claims
- 1942US7223794B2Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthaseASTRAZENECA AB·Filed 2002·Granted May 29, 2007·0 cites·21 claims
- 2042US2011190309A1PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A Beta2-ADRENOCEPTOR AGONISTFORD RHONAN·Filed 2009·Application pending·0 cites
- 2142US2005203172A1Novel compoundsFiled 2003·Application pending·0 cites
- 2242US2006122195A1Sulphonamide compounds that modulate chemokine receptor activity (ccr4)HARRISON RICHARD·Filed 2004·Application pending·0 cites
- 2342US2010113510A1Quinuclidinol derivatives as muscarinic receptor antagonistsFORD RHONAN·Filed 2007·Application pending·0 cites
- 2440US7119109B2Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthaseASTRAZENECA AB·Filed 2002·Granted Oct 10, 2006·0 cites·15 claims
- 2540US2004176422A1Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthaseFiled 2002·Application pending·0 cites
- 2639US2012329775A1Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750FORD RHONAN·Filed 2012·Application pending·0 cites
- 2737US11274092B2Potassium channel inhibitorsACESION PHARMA APS·Filed 2017·Granted Mar 15, 2022·0 cites·20 claims
- 2837US2021395242A1Heterocyclic compounds as ahr modulatorsJAGUAHR THERAPEUTICS PTE LTD·Filed 2019·Application pending·0 cites
- 2935US2004242871A1Novel arylheteroalkylamine derivativesFiled 2002·Application pending·0 cites
- 3033US2013030001A1Quinuclidine derivatives as muscarinic m3 receptor antagonistsPULMAGEN THERAPEUTICS SYNERGY·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →